HCW Biologics Inc. (HCWB)
NASDAQ: HCWB · IEX Real-Time Price · USD
0.620
-0.040 (-6.06%)
Jul 19, 2024, 4:00 PM EDT - Market closed

HCW Biologics Revenue

HCW Biologics had revenue of $1.16M in the twelve months ending March 31, 2024, with 43.63% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $614.75K with 4,805.03% year-over-year growth. In the year 2023, HCW Biologics had annual revenue of $560.36K.

Revenue (ttm)
$1.16M
Revenue Growth
+43.63%
P/S Ratio
20.17
Revenue / Employee
$25,835
Employees
45
Market Cap
23.45M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023560.36K-2.03M-78.33%
Dec 31, 20222.59M--
Dec 31, 20210--
Dec 31, 20204.10M--
Dec 31, 20190--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Nephros 14.06M
NeuroOne Medical Technologies 3.73M
Sol-Gel Technologies 1.72M
Can-Fite BioPharma 743.00K
Biora Therapeutics 544.00K
Revenue Rankings